These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15635191)

  • 1. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug.
    Niwa T; Inoue S; Shiraga T; Takagi A
    Biol Pharm Bull; 2005 Jan; 28(1):188-91. PubMed ID: 15635191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin-3 receptor antagonists on cytochrome P450 activities in human liver microsomes.
    Niwa T; Yamamoto S; Saito M; Kobayashi N; Ikeda K; Noda Y; Takagi A
    Biol Pharm Bull; 2006 Sep; 29(9):1931-5. PubMed ID: 16946512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes.
    Niwa T; Yamamoto S; Saito M; Shiraga T; Takagi A
    Yakugaku Zasshi; 2007 Jan; 127(1):209-16. PubMed ID: 17202802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2004 Jul; 27(7):1151-3. PubMed ID: 15256760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Mar; 27(3):415-7. PubMed ID: 14993813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probucol on cytochrome P450 activities in human liver microsomes.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
    Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
    Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 May; 25(5):682-5. PubMed ID: 12033517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.
    Niwa T; Shiraga T; Takagi A
    Biol Pharm Bull; 2005 Sep; 28(9):1805-8. PubMed ID: 16141567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes.
    Cohen LH; van Leeuwen RE; van Thiel GC; van Pelt JF; Yap SH
    Biopharm Drug Dispos; 2000 Dec; 21(9):353-64. PubMed ID: 11523064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes.
    Niwa T; Inoue-Yamamoto S; Shiraga T; Takagi A
    Biol Pharm Bull; 2005 Sep; 28(9):1813-6. PubMed ID: 16141569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
    Danek PJ; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
    Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
    Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
    Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
    Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin-II receptor antagonists.
    Taavitsainen P; Kiukaanniemi K; Pelkonen O
    Eur J Clin Pharmacol; 2000 May; 56(2):135-40. PubMed ID: 10877007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.